Seattle Genetics and Millennium Highlight Pivotal Data on ADCETRIS ... (press release)
ADCETRIS was granted accelerated approval by the US Food and Drug Administration in August 2011 for two indications: (1) the treatment of patients with HL after failure of autologous stem cell transplant (ASCT) or after failure of at least two prior ...
Seattle Genetics Reports Data From Multiple Presentations on ADCETRIS(TM ...MarketWatch (press release)

all 29 news articles »